Oxford University Innovation
Accelerator/Incubator
Active
Oxford, United Kingdom
65
3M
55
1.76
2
0.15
3
- Areas of investment
Summary
In 1987 was created Oxford University Innovation, which is appeared as Corporate Investor. The leading representative office of defined Corporate Investor is situated in the Oxford. The company was established in Europe in United Kingdom.
Among the most popular fund investment industries, there are Medical, Information Technology. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United Kingdom. The fund has no specific favorite in a number of founders of portfolio startups. In case when startup counts 5+ of the founder, the chance for it to get the investment is meager. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Genomics, Oxford MEStar, GYANA.
The typical case for the fund is to invest in rounds with 1-2 participants. Despite the Oxford University Innovation, startups are often financed by Oxford Sciences Innovation, Parkwalk Advisors, EASME - EU Executive Agency for SMEs. The meaningful sponsors for the fund in investment in the same round are Parkwalk Advisors, Oxford Investment Consultants LLP, IP Group Plc. In the next rounds fund is usually obtained by Oxford Sciences Innovation, Innovate UK, IP Group Plc.
The overall number of key employees were 10.
This Oxford University Innovation works on 23 percentage points less the average amount of lead investments comparing to the other organizations. Speaking about the real fund results, this Corporate Investor is 7 percentage points less often commits exit comparing to other organizations. The important activity for fund was in 2013. Despite it in 2019 the fund had an activity. The typical startup value when the investment from Oxford University Innovation is 10-50 millions dollars. The fund is constantly included in 2-6 investment rounds annually. The usual things for fund are deals in the range of 5 - 10 millions dollars. The top amount of exits for fund were in 2018.
Investor highlights
- Industry generalist
- Yes
- Industry focus
- Stage focus
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 65
- Lead investments
- 2
- Exits
- 3
- Rounds per year
- 1.76
- Follow on index
- 0.15
- Investments by industry
- Software (25)
- Artificial Intelligence (17)
- Biotechnology (13)
- Health Care (11)
- Machine Learning (11) Show 94 more
- Investments by region
-
- United Kingdom (60)
- Netherlands (1)
- Canada (1)
- United States (2)
- Switzerland (1)
- Peak activity year
- 2017
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 7
- Avg. valuation at time of investment
- 2M
- Group Appearance index
- 0.49
- Avg. company exit year
- 4
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
CryoLogyx | 18 Mar 2024 | Seed | 685K | Coventry, Coventry, United Kingdom | |
OxCEPT | 30 Jan 2014 | Software, Information Technology, Cyber Security, Security | Seed | 342K | British Columbia, Vancouver, Canada |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.